tryptophan has been researched along with oxidopamine in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsumoto, M; Saito, H; Smith, CB; Togashi, H; Yoshioka, M | 1 |
| Elbal, MT; Taxi, J | 1 |
| Moore, KE; Nielsen, JA | 1 |
| Baker, G; McGregor, A; Roberts, DC | 1 |
| Thornton, E; Vink, R | 1 |
| Corrigan, F; Hassall, MM; Thornton, E; Vink, R | 1 |
| Banerjee, E; Nandagopal, K | 1 |
| Eskow Jaunarajs, KL; Figge, DA; Standaert, DG | 1 |
| Bansal, Y; Bhandari, R; Kuhad, A; Kumar, B; Saroj, P; Singh, R; Sodhi, RK | 1 |
| Alavinejad, N; Apetz, N; Drzezga, A; Endepols, H; Neumaier, B; Vus, S; Zischler, J; Zlatopolskiy, BD | 1 |
1 review(s) available for tryptophan and oxidopamine
| Article | Year |
|---|---|
Does serotonin deficit mediate susceptibility to ADHD?
Topics: Adolescent; Animals; Animals, Newborn; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Corpus Striatum; Disease Models, Animal; Dopamine; Gene-Environment Interaction; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Inhibition, Psychological; Mice, Knockout; Multifactorial Inheritance; Nerve Tissue Proteins; Neurotransmitter Transport Proteins; Oxidopamine; Prefrontal Cortex; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Serotonin, 5-HT1B; Selective Serotonin Reuptake Inhibitors; Serotonin; Tryptophan | 2015 |
9 other study(ies) available for tryptophan and oxidopamine
| Article | Year |
|---|---|
Alpha 2-adrenoceptor modulation of 5-HT biosynthesis in the rat brain.
Topics: 5-Hydroxytryptophan; Adrenergic alpha-Antagonists; Animals; Brain Chemistry; Clonidine; Dioxanes; Idazoxan; Male; Norepinephrine; Oxidopamine; Raphe Nuclei; Rats; Rats, Wistar; Receptors, Adrenergic, alpha; Serotonin; Tryptophan | 1992 |
Immunohistochemical identification of serotonin and noradrenalin containing structures within the nerve plexuses of rat ileum.
Topics: 5,7-Dihydroxytryptamine; Animals; Female; Hydroxydopamines; Ileum; Male; Myenteric Plexus; Norepinephrine; Oxidopamine; Pargyline; Rats; Rats, Inbred Strains; Reserpine; Serotonin; Tryptophan | 1989 |
6-Hydroxydopamine and 5,7-dihydroxytryptamine selectively reduce dopamine and 5-hydroxytryptamine metabolites in cerebroventricular perfusates of rats.
Topics: 5,7-Dihydroxytryptamine; Animals; Cerebral Ventricles; Dihydroxytryptamines; Dopamine; Haloperidol; Hydroxydopamines; Injections, Intraventricular; Male; Oxidopamine; Perfusion; Rats; Rats, Inbred Strains; Serotonin; Tryptophan | 1983 |
Effect of 6-hydroxydopamine lesions of the amygdala on intravenous cocaine self-administration under a progressive ratio schedule of reinforcement.
Topics: 3,4-Dihydroxyphenylacetic Acid; 5,7-Dihydroxytryptamine; Amygdala; Analysis of Variance; Animals; Behavior, Animal; Benzazepines; Brain; Chlordiazepoxide; Cocaine; Desipramine; Dopamine; Estrus; Female; Fluoxetine; Ibotenic Acid; Injections, Intravenous; Male; Organ Specificity; Oxidopamine; Rats; Rats, Wistar; Self Administration; Time Factors; Tryptophan | 1994 |
Treatment with a substance P receptor antagonist is neuroprotective in the intrastriatal 6-hydroxydopamine model of early Parkinson's disease.
Topics: Animals; Anti-Inflammatory Agents; Blood-Brain Barrier; Cells; Dopaminergic Neurons; Inflammation; Male; Motor Activity; Neurokinin-1 Receptor Antagonists; Neuroprotective Agents; Oxidopamine; Parkinson Disease, Secondary; Piperidines; Rats; Rats, Sprague-Dawley; Rotarod Performance Test; Substance P; Substantia Nigra; Tryptophan | 2012 |
The NK1 receptor antagonist N-acetyl-L-tryptophan reduces dyskinesia in a hemi-parkinsonian rodent model.
Topics: Adrenergic Agents; Analysis of Variance; Animals; Antiparkinson Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Functional Laterality; Levodopa; Male; Medial Forebrain Bundle; Motor Activity; Oxidopamine; Parkinsonian Disorders; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Time Factors; Tryptophan; Tyrosine 3-Monooxygenase | 2014 |
Dynamic DNA Methylation Regulates Levodopa-Induced Dyskinesia.
Topics: Analysis of Variance; Animals; Antiparkinson Agents; Corpus Striatum; Dioxygenases; Disease Models, Animal; DNA Methylation; Dopamine; Dyskinesia, Drug-Induced; Enzyme Inhibitors; GADD45 Proteins; Gene Expression Regulation; Immunoprecipitation; Intracellular Signaling Peptides and Proteins; Levodopa; Male; Medial Forebrain Bundle; Oxidopamine; Parkinson Disease; Parkinson Disease, Secondary; Phthalimides; Rats; Rats, Sprague-Dawley; Tryptophan | 2016 |
IDO-1 inhibition protects against neuroinflammation, oxidative stress and mitochondrial dysfunction in 6-OHDA induced murine model of Parkinson's disease.
Topics: Animals; Indoleamine-Pyrrole 2,3,-Dioxygenase; Male; Mice; Mice, Inbred BALB C; Mitochondria; Neuroprotective Agents; Oxidative Stress; Oxidopamine; Parkinsonian Disorders; Tryptophan | 2021 |
Imaging of cerebral tryptophan metabolism using 7-[
Topics: Animals; Disease Models, Animal; Fluorine Radioisotopes; Hippocampus; Kynurenine; Male; Melatonin; Oxidopamine; Parkinson Disease; Pineal Gland; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Long-Evans; Serotonin; Tryptophan | 2022 |